Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. TRANSACALM 100 mg (trimébutine)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

TRANSACALM 100 mg (trimébutine)

Medicine - Posted on Mar 06 2002 - Updated on Jun 12 2019
Active substance (DCI)
  • trimébutine
history (1)
  • 3/6/02

    TRANSACALM 100 mg (trimébutine)

    Avis favorable au maintien de l'inscription sur la liste des médicaments remboursables aux assurés sociaux dans l'indication...
    icône flèche
Technical information
ATC code
  • A03AA05
Manufacturer
AJC PHARMA
Presentation

TRANSACALM 100 mg, comprimés (20)

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
PcP66uEfkSHcGRF5